InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (18 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
18
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the complete record of transactions filed by Rawcliffe Adrian, Director General. Officer active across 3 companies, notably Adaptimmune Therapeutics PLC. Cumulatively, 21 reports have been recorded. Split: 0 buy · 18 sells. Total volume traded: €371k. Activity tracked since 28 June 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Rawcliffe Adrian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones21 en total
12.700 títulos@ 5,29 US$100.0% de su flujoCommon StockSEC:0001193125-26-349962:0
42.000 títulos@ 5,97 US$69.5% de su flujoOrdinary SharesSEC:0001193125-25-314742:0
16.115 títulos@ 6,79 US$100.0% de su flujoOrdinary SharesSEC:0001193125-25-283619:0
12.700 títulos0Ordinary SharesSEC:0000950170-25-108286:0
30.601 títulos@ 0,5808 US$5.1% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-004605:0
12.539 títulos@ 0,5879 US$2.1% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-003775:0
16.115 títulos0Ordinary SharesSEC:0000950170-24-097290:0
9304 títulos@ 0,79 US$2.0% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-004564:0
11.945 títulos@ 0,8367 US$2.7% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-003742:0
2403 títulos@ 0,78 US$0.5% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-097853:0
2333 títulos@ 0,92 US$0.6% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-075407:0
10.057 títulos@ 1,858 US$5.1% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-004379:0
13.042 títulos@ 1,7468 US$6.3% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-003534:0
5073 títulos@ 1,694 US$2.4% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-001088:0
2536 títulos@ 1,9689 US$1.5% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-097135:0
2562 títulos@ 1,63 US$1.2% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-074926:0
11.096 títulos@ 3,1918 US$14.2% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005053:0
14.362 títulos@ 3,5567 US$20.7% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004149:0
5532 títulos@ 4,0642 US$9.1% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001668:0
2782 títulos@ 5,195 US$5.6% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-112179:0
2794 títulos@ 4,37 US$4.7% de su flujoAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-086385:0
21 de 21 declaraciones
About Rawcliffe Adrian
Chief Executive Officer at Adaptimmune Therapeutics PLC and Director at Wave Life Sciences Ltd., Rawcliffe Adrian has 20 filings in total. Across the 20 sampled filings between 2021-06-28 and 2025-12-10, the recorded transactions are all disposals, with total sales of EUR 312383 and no purchases.
